Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21349634 | 1.00 | ALDH1A1 (0.57) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL20468321 | 1.00 | ALDH1A1 (0.57) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL4088388 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL23561000 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL23352964 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL23221351 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL13007137 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL18900975 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL8840602 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A | |
| SCHEMBL69669 | 0.97 | ALDH1A1 (0.53) | ALDH1A1THRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3560499-A1 | DIHYDROPTERIDINONES FOR THE TREATMENT OF CANCER DISEASES | Boehringer Ingelheim International GmbH (DE) | 2019-10-30 | — | — | EP | disclosed |
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO, INC. | 2017-07-20 | — | — | US | disclosed |
| US-5852023-A | Cyclohexylamino and cycloalkoxy nitrogen heterocycles, processes for their preparation, and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1998-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | CD44, MSN, AS3MT | ALDH1A1 2151/4885THRB 2871/4885MEN1 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.